Hidradenitis Suppurativa (HS) is a chronic, systemic, immune-mediated skin disease which affects between 1-3% of the global population however the diagnosis is often delayed or the condition is misdiagnosed with the true prevalence unknown.
Helping Canadian Dermatologists better manage HS
• Communicate the latest HS management techniques
• Create HS research opportunities and education for Canadian Dermatologists and mentorship for residents
• Establish cross-specialty dialogue to improve HS patient outcomes
• Collaborate with international HS foundations to optimize research, education and patient care